TMR: Reviving Cardiac Lasers
Twenty years after it first burst onto the scene, cardiac laser technology is finally getting hot--kind of. With the advent of new procedures, TMR and PMR, to treat severe angina, many if not most large cardiovascular companies are getting into lasers again. But they're often hedging their bets, acquiring simply marketing or distribution rights, rather than making an outright acquisition.
You may also be interested in...
While endocrine-disrupting evidence was inconclusive, the Scientific Committee on Consumer Safety recommends more conservative limits on use of homosalate, octocrylene and benzophenone-3 in cosmetic products compared with current requirements under the European Cosmetics Product Regulation.
The risk of inadvertently growing SARS-CoV-2 virus in cell and gene therapies and possibly infecting patients and workers should be assessed and mitigated, the agency advises.
Move was meant to preempt others’ efforts to secure the next six months of Regeneron’s COVID-19 antibody therapeutic.